Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

IDH1/2 mutations predict a distinct high-risk subset in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia

Lijuan Hu, Sheng-Ye Lu, Lu Yu, Zongru Li, Hao Jiang, Xiaohui Zhang, Lanping Xu, Yu Wang, Qian Jiang, Xiaojun Huang

Blood (2025) 146 (Supplement 1): 3374.

https://doi.org/10.1182/blood-2025-3374

Published: 2025

Journal Articles

Selecting the optimal bridging therapy for B-ALL: A multicenter comparison of blinatumomab, inotuzumab ozogamicin, and CAR-T prior to allo-HSCT

Ao-Ran Zhang, Guanhua Hu, Xianying Yin, Sheng-Ye Lu, Xiao-Dong Mo, Yuqian Sun, Yu Wang, Lanping Xu, Xiaohui Zhang, Xiangyu Zhao, Xiaojun Huang, Yi-Fei Cheng, Meng Lv

Blood (2025) 146 (Supplement 1): 4298.

https://doi.org/10.1182/blood-2025-4298

Published: 2025

Journal Articles

A Completely Oral Regimen Including Oral Etoposide As Cytoreductive Chemotherapy Combined with All Trans Retinoic Acid and Oral Arsenic for Induction Therapy in Patients with High-Risk APL：Comparable to Intravenous Cytoreductive Therapy

Feifei Tang, Wen-Bing Duan, Xiao-Hong Liu, Sheng-Ye Lu, Xiao-Su Zhao, Ya-Zhen Qin, Jin-Song Jia, Jing Wang, Li-Zhong Gong, Qian Jiang, Zhao Ting, Hong-Xia Shi, Ying-Jun Chang, Xiao-Jun Huang, Hao Jiang

Blood (2023) 142 (Supplement 1): 4288.

https://doi.org/10.1182/blood-2023-188657

Published: 2023

Journal Articles

CD4 + CD25 - CD69 + t Cells Is a Novel Subset of Regulatory T Cells Involved In the Prevention of Acute Graft-Versus-Host Disease In Human

Sheng-Ye Lu, Ph.D., candidate, Xiao Jun Huang, M.D, Kai-Yan Liu, M.D, and, PhD, Dai-Hong Liu, M.D, and, PhD, Lan-Ping Xu, M.D

Blood (2010) 116 (21): 1250.

https://doi.org/10.1182/blood.V116.21.1250.1250

Published: 2010

Journal Articles

IL-17-Producing T Cells Contribute to Mediate Acutegraft-Versus-Disease In Patients Undergoing Unmanipulated Blood and MarrowTransplantation

Xiang-Yu Zhao, Ling-Ling Xu, Sheng-Ye Lu, Kai-Yan Liu, Lan-Ping Xu, Dai-Hong Liu, Xiao Jun Huang

Blood (2010) 116 (21): 2310.

https://doi.org/10.1182/blood.V116.21.2310.2310

Published: 2010

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

IDH1/2 mutations predict a distinct high-risk subset in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia

Selecting the optimal bridging therapy for B-ALL: A multicenter comparison of blinatumomab, inotuzumab ozogamicin, and CAR-T prior to allo-HSCT

A Completely Oral Regimen Including Oral Etoposide As Cytoreductive Chemotherapy Combined with All Trans Retinoic Acid and Oral Arsenic for Induction Therapy in Patients with High-Risk APL：Comparable to Intravenous Cytoreductive Therapy

CD4 + CD25 - CD69 + t Cells Is a Novel Subset of Regulatory T Cells Involved In the Prevention of Acute Graft-Versus-Host Disease In Human

IL-17-Producing T Cells Contribute to Mediate Acutegraft-Versus-Disease In Patients Undergoing Unmanipulated Blood and MarrowTransplantation

Email alerts

ASH Publications

American Society of Hematology

Update search

IDH1/2 mutations predict a distinct high-risk subset in Philadelphia chromosome-negative B-cell acute lymphoblastic leukemia

Selecting the optimal bridging therapy for B-ALL: A multicenter comparison of blinatumomab, inotuzumab ozogamicin, and CAR-T prior to allo-HSCT

A Completely Oral Regimen Including Oral Etoposide As Cytoreductive Chemotherapy Combined with All Trans Retinoic Acid and Oral Arsenic for Induction Therapy in Patients with High-Risk APL：Comparable to Intravenous Cytoreductive Therapy

CD4 + CD25 - CD69 + t Cells Is a Novel Subset of Regulatory T Cells Involved In the Prevention of Acute Graft-Versus-Host Disease In Human

IL-17-Producing T Cells Contribute to Mediate Acutegraft-Versus-Disease In Patients Undergoing Unmanipulated Blood and MarrowTransplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only